Global private equity and venture capital deal value reached $37.93 billion in February, up 26.6% from January, according to ...

Last month, Ropes & Gray, Morrison & Foerster and Big Four Japanese firm Mori Hamada were seen advising in Boston-based Bain ...

Private equity giant Blackstone is going big on Japan, acquiring a majority stake in the country’s leading contract research ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Hookipa Pharma (HOOK – Research Report) on February 28 and set a price target of $2.00. The company’s shares closed yesterday at ...

Blackstone’s deal for CMIC is the second by a major global private equity firm in the past month in Japan’s pharmaceutical sector. In February, Bain Capital said it agreed to acquire Mitsubishi Tanabe ...

Operator: Good day, everyone and welcome to the Bain Capital Specialty Finance Fourth Quarter and Fiscal Year Ended December 31, 2024 Earnings Conference Call. At this time, all participants are ...

Blackstone Inc. is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from ...

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – Research analysts at Roth Capital dropped their Q1 2025 EPS estimates for shares of Nuvectis Pharma in a report issued on Tuesday ...

LG Chem set to commence production of bio-based acrylic acid; Moeve announces plan to develop 30 biomethane plants in Spain; BP plans to sell its Ruhr Oel GmbH – BP Gelsenkirchen business; Evonik form ...

With the possibility of Bain Capital and Dr Reddy's entry in the race to acquire promoter's stake in Cipla, competition has now intensified as firms like Torrent Pharma and Blackstone have already ...